The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
The closing price of Generation Bio Co (NASDAQ: GBIO) was $0.88 for the day, down -4.35% from the previous closing price of $0.92. In other words, the price has decreased by -$4.35 from its previous closing price. On the day, 1.15 million shares were traded. GBIO stock price reached its highest trading level at $1.007 during the session, while it also had its lowest trading level at $0.857.
Ratios:
Our analysis of GBIO’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 6.34 and its Current Ratio is at 6.34. In the meantime, Its Debt-to-Equity ratio is 0.90 whereas as Long-Term Debt/Eq ratio is at 0.79.
On November 08, 2022, Canaccord Genuity started tracking the stock assigning a Buy rating and target price of $9.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jan 10 ’25 when Quinn Anthony G. bought 125,791 shares for $0.96 per share. The transaction valued at 120,759 led to the insider holds 214,286 shares of the business.
Quinn Anthony G. bought 85,000 shares of GBIO for $82,450 on Jan 13 ’25. The Director now owns 299,286 shares after completing the transaction at $0.97 per share. On Jul 01 ’24, another insider, Paone Antoinette, who serves as the CHIEF OPERATING OFFICER of the company, sold 6,719 shares for $2.74 each. As a result, the insider received 18,410 and left with 13,807 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GBIO now has a Market Capitalization of 58777664 and an Enterprise Value of -32213316. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.16 while its Price-to-Book (P/B) ratio in mrq is 0.56. Its current Enterprise Value per Revenue stands at -1.734 whereas that against EBITDA is 0.349.
Stock Price History:
The Beta on a monthly basis for GBIO is 2.73, which has changed by -0.4860335 over the last 52 weeks, in comparison to a change of 0.23147523 over the same period for the S&P500. Over the past 52 weeks, GBIO has reached a high of $4.65, while it has fallen to a 52-week low of $0.75. The 50-Day Moving Average of the stock is -37.76%, while the 200-Day Moving Average is calculated to be -64.82%.
Shares Statistics:
GBIO traded an average of 303.77K shares per day over the past three months and 561000 shares per day over the past ten days. A total of 66.75M shares are outstanding, with a floating share count of 42.51M. Insiders hold about 36.35% of the company’s shares, while institutions hold 66.05% stake in the company. Shares short for GBIO as of 1735603200 were 1762267 with a Short Ratio of 5.80, compared to 1732838400 on 1528113. Therefore, it implies a Short% of Shares Outstanding of 1762267 and a Short% of Float of 4.4099998000000005.
